Using historical control information for the design and analysis of clinical trials with overdispersed count data

Collection, synthesis, and interpretation of evidence: a proof-of-concept study in COPD

(2013) L. Di Scala et al.   STATISTICS IN MEDICINE

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

(2012) Wolfgang Hueber et al.   GUT

A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis

(2012) T Saida et al.   Multiple Sclerosis Journal

The network meta-analytic-predictive approach to non-inferiority trials

(2012) Heinz Schmidli et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials

(2011) Brian P. Hobbs et al.   BIOMETRICS

Incorporation of historical data in the analysis of randomized therapeutic trials

(2011) Charlotte Rietbergen et al.   Contemporary Clinical Trials

Bayesian Statistics in Medical Devices: Innovation Sparked by the FDA

(2011) Gregory Campbell   Journal of Biopharmaceutical Statistics

Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design

(2011) Richard Nicholas et al.   Multiple Sclerosis Journal

Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group

(2011) Jacqueline A. French et al.   Neurotherapeutics

Designing a non-inferiority study in kidney transplantation: a case study

(2011) Steffen Witte et al.   PHARMACEUTICAL STATISTICS

The inclusion of historical control data may reduce the power of a confirmatory study

(2011) Robert L. Cuffe   STATISTICS IN MEDICINE

Access to orphan drugs despite poor quality of clinical evidence

(2010) Alain G. Dupont et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Summarizing historical information on controls in clinical trials

(2010) Beat Neuenschwander et al.   Clinical Trials

Blinded Sample Size Reestimation with Negative Binomial Counts in Superiority and Non-inferiority Trials

(2010) T. Friede et al.   METHODS OF INFORMATION IN MEDICINE

Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity

(2010) CJ Morgan et al.   Multiple Sclerosis Journal

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

(2010) Gavin Giovannoni et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach

(2009) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

A note on the power prior

(2009) Beat Neuenschwander et al.   STATISTICS IN MEDICINE

Will Rogers phenomenon in multiple sclerosis

(2008) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

A re-evaluation of random-effects meta-analysis

(2008) Julian P. T. Higgins et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

(2008) G Comi et al.   LANCET

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

(2008) Ludwig Kappos et al.   LANCET

The distribution of new enhancing lesion counts in multiple sclerosis: further explorations

(2008) IJ van den Elskamp et al.   Multiple Sclerosis Journal

Critical aspects of the Bayesian approach to phase I cancer trials

(2008) Beat Neuenschwander et al.   STATISTICS IN MEDICINE